摘要
目的 讨论及研究阿托伐他汀联合曲美他嗪治疗冠心病的临床效果以及药学分析。方法 纳入本次研究患者的数量为120例，时间范围为2024年1月份至2024年12月份，盲法分成对照组和实验组，对照组曲美他嗪，实验组在对照组基础上提供阿托伐他汀治疗，分析两组患者血脂指标以及心功能指标。结果 实验组患者心功能指标显优，p<0.05，对比血脂指标，实验组显佳，p<0.05。结论 对冠心病患者提供阿托伐他汀联合曲美他嗪治疗，可以改善心功能指标，改善患者的血脂水平，值得提倡。
关键词： 阿托伐他汀；曲美他嗪；冠心病；临床疗效；药学分析
Abstract
Objective To investigate the clinical efficacy and pharmacological analysis of atorvastatin combined with trimetazidine in treating coronary heart disease. Methods A total of 120 patients were enrolled from January to December 2024. They were randomly assigned into a control group receiving trimetazidine and an experimental group receiving atorvastatin in addition to trimetazidine. Both groups’ lipid levels and cardiac function indicators were analyzed. Results The experimental group showed significantly better cardiac function (p<0.05) and lipid levels (p<0.05). Conclusion The combination therapy of atorvastatin and trimetazidine in coronary heart disease patients can improve cardiac function and lipid profiles, making it clinically recommended.
Key words： Atorvastatin; Trimetazidine; Coronary heart disease; Clinical efficacy; Pharmacological analysis
参考文献 References
[1] 刘彦.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果与药学机制分析[J].智慧健康,2023,9(22):70-73.
[2] 王建坤.阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效观察分析[J].中国科技期刊数据库 医药,2023(3):67-69.
[3] 佟素萍.阿托伐他汀联合曲美他嗪治疗冠心病临床疗效分析[J].中文科技期刊数据库（引文版）医药卫生, 2023(5):62-64.
[4] 陈志炯,林阳惠.曲美他嗪联合阿托伐他汀治疗冠心病的临床疗效[J].临床合理用药杂志,2023,16(27):5-711.
[5] 叶珊珊,陆炜,李莹.曲美他嗪联合阿托伐他汀治疗老年冠心病心绞痛的疗效及对心电图参数、超声参数及细胞因子的影响[J].中国老年学杂志,2023,43(17):4100-4103.
[6] 李碧艳,张志超.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果[J].临床合理用药杂志,2022,15(8):58-61.
[7] 王慧,毕艺.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常的临床疗效及安全性[J].当代医学,2022, 28(20):125-127.
[8] 佘进.冠心病应用曲美他嗪联合阿托伐他汀治疗的效果及TC、TG水平影响分析[J].中文科技期刊数据库（引文版）医药卫生,2022(10):26-29.
[9] Fan Y .Effectiveness of Atorvastatin Combined with Trimetazidine in the Treatment of Coronary Heart Disease in the Elderly and Their Effect on Cardiac Function[J]. Journal of Clinical and Nursing Research, 2024,8(5):266-270.
[10] Xiaoliang S ,Yuqi C ,Yongjun C , et al.Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients with severe coronary artery disease: A prospective, self-controlled study.[J].Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,2021, 29(5):1-11.